OPEN-LABEL, SINGLE-ARM, MULTICENTER, LONG-TERM STUDY TO EVALUATE SAFETY AND EFFICACY OF BRIVARACETAM USED AS ADJUNCTIVE TREATMENT IN PEDIATRIC SUBJECTS WITH EPILEPSY
Clinical Trial Grant
Administered By
Pediatrics, Neurology
Awarded By
UCB Pharma, Inc.
Start Date
July 17, 2018
End Date
July 31, 2022
Administered By
Pediatrics, Neurology
Awarded By
UCB Pharma, Inc.
Start Date
July 17, 2018
End Date
July 31, 2022